Engineers Gate Manager LP Charles River Laboratories International, Inc. Transaction History

Engineers Gate Manager LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $423,267 - $484,416	2,304 New	2,304 $484,000
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $408,806 - $518,645	2,074 New	2,074 $451,000
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $2.08 Million - $3.08 Million	10,195 Added 459.86%	12,412 $2.66 Million
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $2.56 Million - $3.63 Million	-10,014 Reduced 81.87%	2,217 $630,000
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $1.86 Million - $2.38 Million	5,303 Added 76.54%	12,231 $4.61 Million
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $2.58 Million - $3.18 Million	6,928 New	6,928 $2.86 Million
Q1 2021 May 17, 2021	SELL	$249.67 - $299.48 $280,379 - $336,316	-1,123 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $212,010 - $241,252	-955 Reduced 45.96%	1,123 $281,000
Q3 2020 Nov 16, 2020	SELL	$175.56 - $226.45 $34,234 - $44,157	-195 Reduced 8.58%	2,078 $471,000
Q2 2020 Aug 17, 2020	BUY	$118.84 - $189.72 $69,283 - $110,606	583 Added 34.5%	2,273 $396,000
Q1 2020 May 15, 2020	BUY	$98.9 - $178.34 $167,141 - $301,394	1,690 New	1,690 $213,000

691

52M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.